Search…

Kangxinuo (688185.SH): Approval obtained for clinical trial of restructuring trivalent polio vaccine (Sf-RVN cells)

17/07/2025

Smart Finance APP News, Kangxinuo (688185.SH) announced that the company recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration regarding the restructuring of the trivalent polio vaccine (Sf-RVN cells), agreeing to conduct clinical trials for the prevention of poliomyelitis caused by type I, II, and III poliovirus infections.

Latest

2 m ago

On Wednesday at the New York closing bell, the ICE US Dollar Index fell by 0.21% to 98.412 points, with an intraday trading range of 98.912-97.714 points. The report about "Trump seeking congressional opinions on dismissing Fed Chairman Powell" brought a V-shaped trend to the dollar. The Bloomberg Dollar Index fell by 0.23% to 1204.62 points, with an intraday trading range of 1210.13-1198.82 points.

2 m ago

Chicago soybean futures rose by about 1.8%, while corn rose by over 1.1%.

2 m ago

The onshore Chinese yuan against the US dollar closed at 1.1771 at 03:00 Beijing time, up 39 points from the Tuesday night session. The trading volume was 32.617 billion US dollars.

11 m ago

Trump: We must take action against the drug cartels in Mexico.

17 m ago

Brazilian Coffee Exporters Association CECAFE: Brazil's June exports of 1.82 million bags of 60 kg Arabica coffee decreased by 26.9% compared to the same period last year.

See all latest